Market Place
Sourcing Support
Harvard Partners with Children’s Hospital on Esophageal Atresia
28 Oct 2024 //
#N/A
Harvard Apparatus Regenerative Tech Appoints Mao Zhang To Board Of Directors
27 Aug 2024 //
GLOBENEWSWIRE
Harvard Apparatus Regenerative Tech Secures $5M for Clinical Trial Continuation
26 Aug 2024 //
GLOBENEWSWIRE
Harvard Apparatus Regenerative Technology Announces $5M Financing
26 Aug 2024 //
GLOBENEWSWIRE
Harvard Apparatus Regen Tech Q1 2024 Financials, Highlights
13 May 2024 //
GLOBENEWSWIRE
Harvard Regenerative Technology and McGowan Institute Establish a Collaboration
18 Dec 2023 //
GLOBENEWSWIRE
Harvard Apparatus Regenerative Technology
04 Dec 2023 //
GLOBENEWSWIRE
Harvard Apparatus Regenerative Reports Third Quarter 2023 Financial Results
13 Nov 2023 //
GLOBENEWSWIRE
Harvard Apparatus Regenerative Technology Schedules Conference Call
09 Nov 2023 //
GLOBENEWSWIRE
Approval of an Orphan Disease Application for Cellspan Esophageal Implant by EMA
21 Aug 2023 //
PR NEWSWIRE
Biostage Initiated Study Start-up Activities for Trial in Esophageal Disease
31 May 2023 //
GLOBENEWSWIRE
Biostage Appoints Ron Packard to Board of Directors
10 Apr 2023 //
GLOBENEWSWIRE
Biostage Announces $6 Million Financing to Advance Clinical Trial
06 Apr 2023 //
GLOBENEWSWIRE
Revive Therapeutics Explores the Use of Bucillamine for COVID-19
20 Mar 2020 //
BUSINESSWIRE
Biostage`s regenerative esophagus implant placed on FDA hold
04 Dec 2019 //
FIERCE BIOTECH
Copyright © 2025 LePro PharmaCompass OPC Private Limited, All rights reserved.